mdlinx mdlinx

Residential radon exposure, histologic types, and lung cancer risk. A case-control study in Galicia, Spain Cancer Epidemiology, Biomarkers & Prevention, 05/11/2012

Barros-Dios JM et al. – The presence of airborne radon even at low concentrations poses a risk of developing lung cancer, with tobacco habit increasing considerably this risk.

Methods

  • A hospital-based case–control design was conducted in two Spanish hospitals.
  • Consecutive cases with histologic diagnosis of lung cancer and controls undergoing trivial surgery not tobacco-related were included.
  • Residential radon was measured using standard procedures.
  • Results were obtained using logistic regression.

Results
  • Three hundred and forty-nine cases and 513 controls were included.
  • Radon exposure posed a risk even with a low exposure, with those exposed to 50 to 100 Bq/m3 having an OR of 1.87 [95% confidence interval (CI), 1.21–2.88] and of 2.21 (95% CI, 1.33–3.69) for those exposed to 148 Bq/m3 or more.
  • Tobacco increased appreciably the risk posed by radon, with an OR of 73 (95% CI, 19.88–268.14) for heavy smokers exposed to more than 147 Bq/m3.
  • Less frequent histologic types (including large cell carcinomas), followed by small cell lung cancer, had the highest risk associated with radon exposure.

Read this article on Cancer Epidemiology, Biomarkers & Prevention



Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close